Ying-hua Li

Hengshui, 053000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Expression and Clinical Significance of SOCS1 and SOCS3 in Myelodysplastic Syndrome

Expression and Clinical Significance of SOCS1 and SOCS3 in Myelodysplastic Syndrome

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

Clinical Efficacy and Prognosis of Double-Hit Multiple Myeloma Patients with Deletion P53 Treated with Regimen Based on Bortezomib

Clinical Efficacy and Prognosis of Double-Hit Multiple Myeloma Patients with Deletion P53 Treated with Regimen Based on Bortezomib

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 18, 2020

Outcomes of DNMT3A+ Myelodysplastic Syndrome Patients Treated with Decitabine

Outcomes of DNMT3A+ Myelodysplastic Syndrome Patients Treated with Decitabine

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 18, 2020

Clinical Efficacy of Low-Dose Bortezomib-Based Triple Combination Therapy in the Treatment of Elderly Multiple Myeloma

Clinical Efficacy of Low-Dose Bortezomib-Based Triple Combination Therapy in the Treatment of Elderly Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 23, 2020

Expression Level and Clinical Significance of OTC4 Gene in Patients with Myelodysplastic Syndromes

Expression Level and Clinical Significance of OTC4 Gene in Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 07, 2020

Clinical Efficacy of Low-Dose Decitabine alone for Treatment of Myelodysplastic Syndrome

Clinical Efficacy of Low-Dose Decitabine alone for Treatment of Myelodysplastic Syndrome

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 15, 2019

Effects of Low-Dose Decitabine on Soluble CD44, GDF11 Levels and Hematopoietic Function in Elderly Patients with MDS

Effects of Low-Dose Decitabine on Soluble CD44, GDF11 Levels and Hematopoietic Function in Elderly Patients with MDS

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 19, 2019

Relationship between DNMT1 and Methylation of SHP-1 Promoter 2 in K562 Cells

Relationship between DNMT1 and Methylation of SHP-1 Promoter 2 in K562 Cells

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 19, 2018

Expression of SHP-1 mRNA in Patients with Myelogenous Leukemia and Its Clinical Significance

Expression of SHP-1 mRNA in Patients with Myelogenous Leukemia and Its Clinical Significance

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 22, 2017

Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance

Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 28, 2016

One of the Mechanisms in Blastic Transformation of Chronic Myeloid Leukemia: Epigenetics Abnormality--Review

One of the Mechanisms in Blastic Transformation of Chronic Myeloid Leukemia: Epigenetics Abnormality--Review

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 26, 2016

Overexpression of SHP-1 Enhances the Sensitivity of K562 Cells to Imatinib

Overexpression of SHP-1 Enhances the Sensitivity of K562 Cells to Imatinib

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 26, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026